Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes: a Double Blind RCT

NCT05569772 is registered in ClinicalTrials.gov with Universitaire Ziekenhuizen KU Leuven as lead sponsor.

NCT NCT05569772
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05569772 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes: a Double Blind RCT
Lead sponsor
Universitaire Ziekenhuizen KU Leuven
Phase
Phase 3
Overall status
Recruiting
Start date
September 14, 2023
Completion date
May 31, 2030
Enrollment
252 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

glucose intolerance after a recent history of gestational diabetes